Newsquawk Logo

FDA says as of Oct 14, 2025, J&J Medtech (JNJ) has reported four serious injuries and one death associated with detachable coil system issue

The FDA's announcement regarding serious injuries and one death linked to Johnson & Johnson's detachable coil system raises significant concerns about product safety and regulatory scrutiny.

Newsquawk StaffPublished On the live feed at — 3 more headlines followed before this page went public
Newsquawk headlinesUTC

WEC Energy (WEC) says it will invest USD 12.6bln over five years to add 6,500 MW to its generation fleet, via conference call

Coca-Cola (KO) spokesperson says discontinuing frozen products and exiting frozen can category in response to shifting consumer preferences; frozen products will be discontinued in Q1 2026, with in-store inventory available while supplies last

FDA says as of Oct 14, 2025, J&J Medtech (JNJ) has reported four serious injuries and one death associated with detachable coil system issue

Banxico holds rates at 7.00%, as expected in unanimous decision

Goldman Sachs expects 2025-to-2030 global LNG supply growth to far exceed Asia demand growth

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

For J&J, this could potentially impact their reputation and sales trajectory, as ongoing safety issues may affect investor sentiment and stock performance. Traders should monitor for any further developments, potential recalls, or legal ramifications that might arise from this report.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.